Editor’s Note: The 340B Report team is working hard on a special report on key developments from the 340B Coalition Winter Conference Feb. 10-12 in San Diego. We do not plan to publish this Thursday’s edition. Expect to see a detailed
…Articles by : Tom Mirga, Editor at Large
Think Tank to States: Use 340B to Reduce Drug Prices
States should do more to help hospitals and other providers enroll in the 340B program as a way to lower drug prices, a liberal think tank with ties to the
…Drug manufacturers are doing a better job of providing the Health Resources and Services Administration (HRSA) with timely and accurate data needed to verify their 340B ceiling prices, the head of the federal 340B drug pricing program indicated today. Nonetheless,
…The Trump administration today asked Congress again to require 340B covered entities to report their 340B program savings and uses to the Health Resources and Services Administration (HRSA).
The administration made the request in its proposed federal budget for fiscal
…Beta Testing Is Complete, We Are Live on Substack
We’re happy to report that 340B Report went live on our publishing platform, Substack, today. Moving forward, you’ll
…CMS Takes Another Step Toward Collecting Hospitals’ 340B Acquisition Costs
The Centers for Medicare & Medicaid Services (CMS) has taken another step toward requiring hospitals to let it see their 340B drug acquisition costs so CMS can base the hospitals’
…President Expected to Address Drug Prices in State of the Union Message
In his State of the Union address tonight, President Trump is expected to announce an initiative to make insulin more affordable and to challenge Congress to pass legislation
…CMS Unveils Medicaid Block Grant Option, Ramifications for 340B Unclear
The Centers for Medicare & Medicaid Services (CMS) this morning invited state Medicaid directors to pilot test giving up open-ended federal Medicaid funding for able-bodied adults in exchange for a
…Hospital Group: GAO’s 340B Duplicate Discount Recommendations “Contrary to Federal Law”
Hospital group 340B Health yesterday swung back hard against a congressional watchdog agency’s recommendations for stricter federal policing of 340B duplicate discounts, calling them “misguided, unworkable, and contrary
…BREAKING: GAO Criticizes Policing of 340B Duplicate Discounts
The U.S. Department of Health and Human Services (HHS) lacks “reasonable assurance” that states and healthcare providers are complying with the prohibition against subjecting drug manufacturers to payment of duplicate 340B discounts
…